Skip to content
Search

Latest Stories

UKHSA expands notifiable disease list: Medical professionals must report 8 more diseases

Under the new requirements, labs in England will also be required to report 10 additional pathogens to boost surveillance.

UKHSA expands notifiable disease and pathogen reporting requirements

Robust disease surveillance is vital for effective public health response, says UKHSA

Getty Images

The UK Health Security Agency (UKHSA) has updated Health Protection Notification Regulations (HPNR) requirements, expanding the list of notifiable diseases and pathogens.

From 6 April 2025, registered medical professionals will be required to report suspected cases of 8 additional conditions, besides existing infections.


These include:

  • Middle East respiratory syndrome (MERS)
  • Influenza of zoonotic origin
  • Chickenpox (varicella)
  • Congenital syphilis
  • Neonatal herpes
  • Acute flaccid paralysis (AFP) or acute flaccid myelitis (AFM)
  • Disseminated gonococcal infection (DGI)
  • Creutzfeldt-Jakob disease (CJD)

Under the new requirements, diagnostic laboratories testing human samples in England will also be required to report 10 additional pathogens, including:

  • Middle East respiratory syndrome coronavirus (MERS-CoV)
  • Non-human influenza A subtypes
  • Norovirus
  • Echinococcus spp
  • Tick-borne encephalitis virus (TBEV)
  • Toxoplasma (congenital toxoplasmosis)
  • Trichinella spp
  • Yersinia spp
  • Respiratory syncytial virus (RSV)
  • Candidozyma auris

These changes follow a public consultation and joint assessment by UKHSA and the Department of Health and Social Care (DHSC) to strengthen surveillance of both existing and emerging infectious diseases and improve outbreak response capabilities.

“These expanded reporting requirements will strengthen our ability to detect and respond to infectious disease outbreaks quickly and effectively,” said Dr William Welfare, UKHSA director of health protection operations.

He emphasised that robust disease surveillance is vital for effective public health response as the data gathered through this system helps develop and implement timely public health interventions.

“When registered medical practitioners report certain diseases, UKHSA’s Health Protection Teams will take action.”

“This might include giving antibiotics to people who’ve been in contact with patients, offering vaccines, or advising people to self-isolate. For other diseases, the reports help UKHSA track how illnesses spread and how effective interventions are,” he added.

To streamline the reporting process, UKHSA recently launched an electronic NOIDs system, enabling healthcare professionals to submit notifications online.

This digital system is faster than the old paper-based method, helping UKHSA respond more quickly to health threats and reducing the burden of reporting for healthcare professionals.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
New pharmacy contract: Opportunities and how to unlock them

The future of community pharmacy practice will increasingly be a blended approach of supply and service provision.

Prof. Harry McQuillan

New pharmacy contract: A step forward in securing sector stability

By Prof. Harry McQuillan

The announcement of the new Community Pharmacy Contractual Framework (CPCF) for 2025/26 in England marks a step forward in stabilising the community pharmacy network. With an annual funding commitment of £3.073 billion, an increased medicines margin, and improved service fees, the contract presents opportunities for community pharmacies to expand their role in delivering high-quality healthcare. To truly unlock these opportunities, pharmacies have been asked to align with a future service focused model, one that Numark has been advocating for some time through our 12 Principles of Pharmacy Practice.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
Community pharmacy must now focus on matters in their direct control

The new Community Pharmacy Contractual Framework is a step in the right direction - Victoria Steele

Victoria Steele

Community pharmacy shouldn’t rely solely on CPCF income

Over the coming days much will be/is being written about the Community Pharmacy Contractual Framework and the Independent Economic Review. Emotions are understandably high this week and as everyone has already said, the devil is in the detail.

I must admit to being puzzled by the behaviours that I’m witnessing, and energy being expended at Community Pharmacy England’s door rather than that of government. Only those in the room whilst negotiating will know what information they were dealing with and as is always the case in these situations, they (CPE) are undoubtedly in an unenviable position where nothing they could do would have been right (or certainly not enough).

Keep ReadingShow less